Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K
2.8K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

6.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.0K
2.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.8K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription Reprogramming.

The Journal of clinical investigation·2026
Same author

Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction.

Bioorganic & medicinal chemistry·2024
Same author

Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs.

Cancer discovery·2024
Same author

Patterns in the tapestry of chromatin-bound RB.

Trends in cell biology·2023
Same author

Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of <i>MYC</i> paralogs.

bioRxiv : the preprint server for biology·2023
Same author

Therapy-induced APOBEC3A drives evolution of persistent cancer cells.

Nature·2023

Related Experiment Video

Updated: Mar 18, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.8K

RB1: a prototype tumor suppressor and an enigma.

Nicholas J Dyson1

  • 1Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA.

Genes & Development
|July 13, 2016
PubMed
Summary
This summary is machine-generated.

The retinoblastoma susceptibility gene (RB1) is a key tumor suppressor. Research is clarifying its function, cellular impact after inactivation, and potential for cancer treatments.

Keywords:
E2Fcell proliferationpRBtumor suppressor

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.5K
Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

1.8K

Related Experiment Videos

Last Updated: Mar 18, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.8K
Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.5K
Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

1.8K

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The retinoblastoma susceptibility gene (RB1) was the first tumor suppressor gene identified.
  • RB1 mutations are implicated in retinoblastoma and various other cancers.
  • RB1 is a prototype tumor suppressor due to its early discovery and frequent inactivation.

Purpose of the Study:

  • To review recent developments in RB1 research.
  • To address fundamental questions regarding RB1's function and cellular effects.
  • To explore therapeutic applications of RB1 knowledge in cancer treatment.

Main Methods:

  • Literature review of recent RB1 research.
  • Analysis of established knowledge on RB1's role in transcription regulation and cell proliferation.
  • Synthesis of findings to answer key questions about RB1's mechanism and clinical relevance.

Main Results:

  • RB1's gene product (pRB) is a known regulator of transcription and a negative regulator of cell proliferation.
  • Despite established roles, pRB's precise mechanism of action remains an area of active investigation.
  • Recent research is providing insights into how RB1 inactivation alters cellular processes.

Conclusions:

  • Understanding pRB's function is crucial for comprehending cancer development.
  • Further research into RB1's mechanism of action is needed.
  • Exploiting knowledge of RB1 function holds promise for improved cancer therapies.